SCHEDULE 13G/A: AWM Investment Company Discloses 7.7% Stake in InfuSystem Holdings
Beneficial Ownership Report
AWM Investment Company, Inc. has filed an amended Schedule 13G, reporting a 7.7% beneficial ownership stake in InfuSystem Holdings, Inc. as of March 31, 2025.
Summary
- AWM Investment Company, Inc. (AWM), a Delaware corporation, has filed an Amendment No. 9 to Schedule 13G regarding its beneficial ownership in InfuSystem Holdings, Inc.
- As of March 31, 2025, AWM beneficially owns 1,626,280 shares of InfuSystem Holdings, Inc. Common Stock.
- This ownership represents 7.7% of the class of securities.
- AWM, acting as the investment adviser to Special Situations Life Sciences Fund, L.P. (SSLS), holds sole voting power and sole dispositive power over all 1,626,280 shares held by SSLS.
- David M. Greenhouse and Adam C. Stettner are controlling principals of AWM and members of LS Advisers, L.LC., which is the general partner of SSLS.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership, which is neutral in tone. It does not contain positive or negative performance metrics or strategic updates.
Positives
- The disclosure of a significant institutional stake (7.7%) by AWM Investment Company, Inc. may signal confidence in InfuSystem Holdings, Inc. from a specialized investment firm.
Future Outlook
This Schedule 13G filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance regarding the issuer's future performance or outlook.
Industry Context
This filing indicates continued institutional investor interest in InfuSystem Holdings, Inc., a company operating in the healthcare technology sector. The disclosure of a significant stake by an investment adviser like AWM suggests that the company remains on the radar of specialized funds focusing on life sciences and related industries.
Related Party Transactions
- AWM Investment Company, Inc. is the investment adviser to Special Situations Life Sciences Fund, L.P. (SSLS), which is the entity directly holding the shares.
- David M. Greenhouse and Adam C. Stettner, controlling principals of AWM, are also members of LS Advisers, L.LC., which serves as the general partner of SSLS. This structure defines the beneficial ownership and control over the shares.
Stakeholder Impact
- Shareholders: The disclosure of a significant institutional stake by AWM Investment Company, Inc. provides transparency regarding the ownership structure and may influence investor perception of the company.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Date of event which requires filing of this statement (beneficial ownership calculation date) |
| 05/09/2025 | Date of filing of the Schedule 13G amendment |
Keywords
InfuSystem Holdings, AWM Investment Company, Schedule 13G, beneficial ownership, common stock, institutional investor, healthcare technology, investment adviser
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.